Prosecution Insights
Last updated: May 29, 2026
Application No. 18/115,979

SYSTEM AND METHOD FOR GENERATING CARDIOVASCULAR HEALTH PROGRAMS

Non-Final OA §103
Filed
Mar 01, 2023
Priority
Dec 29, 2020 — CIP of 11/600,374
Examiner
LAM, ELIZA ANNE
Art Unit
3681
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Kpn Innovations LLC
OA Round
3 (Non-Final)
38%
Grant Probability
At Risk
3-4
OA Rounds
1y 1m
Est. Remaining
68%
With Interview

Examiner Intelligence

Grants only 38% of cases
38%
Career Allowance Rate
207 granted / 549 resolved
-14.3% vs TC avg
Strong +30% interview lift
Without
With
+30.5%
Interview Lift
resolved cases with interview
Typical timeline
4y 4m
Avg Prosecution
24 currently pending
Career history
583
Total Applications
across all art units

Statute-Specific Performance

§101
12.5%
-27.5% vs TC avg
§103
69.9%
+29.9% vs TC avg
§102
11.9%
-28.1% vs TC avg
§112
3.7%
-36.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 549 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-3, 6, 7, 11-13, 16, and 17 is/are rejected under 35 U.S.C. 103 as being unpatentable over U.S. Patent Application Publication 2020/0058404 to Nazem et al. in view of U.S. Patent 11,183,080 to Wolf et al. As to claims 1 and 11, Nazem discloses a system for generating cardiovascular health programs, the system comprising: A sensor configured to collect a cardiovascular sample relating to a user (Nazem [0074], [0077], [0080]) a computing device, the computing device configured to: receive at least a cardiovascular sample relating to a user (Nazem [0007]); receive a plurality of physical activities (Nazem paragraph [0010]-[0011]); generate at least a cardiovascular parameter as a function of the at least a cardiovascular sample (Nazem [0013]); determine a cardiovascular profile as a function of the at least a cardiovascular parameter and at least a cardiovascular deficiency, wherein: the at least a cardiovascular deficiency is compared to a cardiovascular threshold (Nazem [0013]); the cardiovascular profile includes a numerical cardiovascular health score correlated to the at least a cardiovascular parameter (Nazem [0013]); and the cardiovascular profile comprises an atherosclerosis indicator correlated to the at least a cardiovascular parameter, wherein the atherosclerosis indicator includes a location in a user’s body wherein a vein or artery is accumulating plaque buildup (Nazem [0071]-[0073]); generate a lifestyle program as a function of the cardiovascular profile, wherein generating the lifestyle program comprises: correlating at least a physical activity from the plurality of physical activities to the at least a cardiovascular parameter (Nazem [0109]); and assigning the at least a physical activity to the user as a function of the correlation (Nazem [0109]). However, Nazem does not explicitly teach identifying, by the computing device, a plurality of nutritional elements as a function of the cardiovascular profile, wherein identifying the plurality of nutritional elements comprises classifying the cardiovascular profile to a cardiovascular disease category using a classifier machine-learning model; train a nutrition element machine-learning model using a first correlation between the identified nutritional elements as a function of the cardiovascular profile and the at least a cardiovascular deficiency, wherein the trained nutrition element machine-learning model is configured to output a nutrition element. Wolf discloses identifying, by the computing device, a plurality of nutritional elements as a function of the cardiovascular profile, wherein identifying the plurality of nutritional elements comprises classifying the cardiovascular profile to a cardiovascular disease category using a classifier machine-learning model; train a nutrition element machine-learning model using a first correlation between the identified nutritional elements as a function of the cardiovascular profile and the at least a cardiovascular deficiency, wherein the trained nutrition element machine-learning model is configured to output a nutrition element, generate a lifestyle program as a function of the nutritional element (Wolf abstract and column 2 lines 53-67 and column 3 lines 1-52). It would have been obvious to utilize machine learning to generate nutritional recommendations for a cardiovascular profile as in Wolf in the system of Nazem to improve the accuracy of nutritional advice. As to claims 2 and 12, see the discussion of claim 1, additionally, Nazem discloses the system wherein generating the lifestyle program comprises receiving a user choice regarding an activity (Nazem [0053]). As to claims 3 and 13, see the discussion of claim 1, additionally, Nazem discloses the system wherein computing device is further configured to generate the lifestyle program using a lifestyle program classifier (Nazem [0053]). As to claims 6 and 16, see the discussion of claim 1, additionally, Nazem discloses the system wherein the computing device is further configured to calculate the numerical cardiovascular health score, wherein calculating the numerical cardiovascular health score comprises: assigning a first numerical score to the at least a cardiovascular parameter as a function of the cardiovascular threshold (Nazem [0094]-[0098]); assigning a second numerical score to at least a physical activity associated with the at least a cardiovascular parameter (Nazem [0094]-[0098]); and calculating the numerical cardiovascular score as a function of the second numerical score and the first numerical score (Nazem [0094]-[0098]). As to claim 7 and 17, see the discussion of claim 6, additionally, Nazem discloses the system wherein the computing device is further configured to minimize the numerical cardiovascular score as a function of the at least a physical activity from the plurality of physical activities (Nazem [0094]-[0098]). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 4, 5, 8-10, 14, 15, and 18-20 is/are rejected under 35 U.S.C. 103 as being unpatentable over U.S. Patent Application Publication 2020/0058404 to Nazem et al. in view of U.S. Patent 11,183,080 to Wolf et al. in view of U.S. Patent Application Publication 2021/0241139 to Jain et al. As to claims 4 and 14, see the discussion of claim 3, however, Nazem does not explicitly teach the system wherein the computing device is further to train a classification machine learning model using a lifestyle training set. Jain discloses wherein the computing device is further to train a classification machine learning model using a lifestyle training set (Jain [0353]). It would have been obvious to one of ordinary skill in the art at the time of the effective filing of the invention by applicant to train a model using lifestyle data as in Jain in the system of Nazem to gain insights using known risk factors to improve the therapeutic value of assigned activities. As to claims 5 and 15, see the discussion of claim 4, additionally, Jain discloses the system wherein the lifestyle training set comprises previous iterations classification machine learning model (Jain [0353] and [0338]). As to claims 8 and 18, see the discussion of claim 1, however, Nazem does not explicitly teach the system wherein generating the lifestyle program comprises generating an activity adherence score. Jain discloses wherein generating the lifestyle program comprises generating an activity adherence score (Jain [0272]). It would have been obvious to one of ordinary skill in the art at the time of the effective filing of the invention by applicant to monitor adherence as in Jain in the system of Nazem to improve patient outcomes by ensuring proper treatment of their conditions. As to claims 9 and 19, see the discussion of claim 1, however, Nazem does not explicitly teach the system wherein the computing device is further configured to modify the activity adherence score. Jain discloses wherein the computing device is further configured to modify the activity adherence score (Jain [0272], [0277]). It would have been obvious to one of ordinary skill in the art at the time of the effective filing of the invention by applicant to monitor adherence as in Jain in the system of Nazem to improve patient outcomes by ensuring proper treatment of their conditions. As to claim 10 and 20, see the discussion of claim 1, however, Nazem does not explicitly teach the system wherein the computing device is further configured to modify the lifestyle program as a function of the activity adherence score. Jain discloses wherein the computing device is further configured to modify the lifestyle program as a function of the activity adherence score (Jain [0272]). It would have been obvious to one of ordinary skill in the art at the time of the effective filing of the invention by applicant to monitor adherence as in Jain in the system of Nazem to improve patient outcomes by ensuring proper treatment of their conditions. Response to Arguments Applicant's arguments filed 4/24/26 have been fully considered but they are not persuasive. The prior rejections under 101 are withdrawn in light of Applicants amendments and arguments. Applicant asserts that the amended subject matter is not taught by the references, the newly added features of the claims are rejected for the reasons set forth above Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Eliza Lam whose telephone number is (571)270-7052. The examiner can normally be reached Monday-Friday 8-4:30PST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Peter Choi can be reached on 469-295-9171. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ELIZA A LAM/Primary Examiner, Art Unit 3681
Read full office action

Prosecution Timeline

Show 1 earlier event
Jan 30, 2025
Non-Final Rejection mailed — §103
Jul 24, 2025
Interview Requested
Jul 30, 2025
Response Filed
Jul 31, 2025
Examiner Interview Summary
Oct 24, 2025
Final Rejection mailed — §103
Apr 24, 2026
Request for Continued Examination
Apr 29, 2026
Response after Non-Final Action
May 20, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12626817
MANAGEMENT OF PHARMACY KITS
1y 11m to grant Granted May 12, 2026
Patent 12620493
THROMBUS TREATMENT METRIC
3y 5m to grant Granted May 05, 2026
Patent 12620470
DYNAMIC EQUIVALENT ON BOARD ESTIMATOR
2y 1m to grant Granted May 05, 2026
Patent 12605565
DELIVERY MACHINE LIMITATION GUIDED RADIATION THERAPY TREATMENT PLANNING
2y 6m to grant Granted Apr 21, 2026
Patent 12597488
USE OF MACHINE LEARNING MODELS FOR PREDICTION OF CLINICAL OUTCOMES
5y 1m to grant Granted Apr 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
38%
Grant Probability
68%
With Interview (+30.5%)
4y 4m (~1y 1m remaining)
Median Time to Grant
High
PTA Risk
Based on 549 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month